> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Higher Dose of Ozempic Diabetes Drug
- URL: https://www.fdaweb.com/fda-approves-higher-dose-of-ozempic-diabetes-drug/
- Published: 2022-03-29T12:00:00.000Z
- Updated: 2026-09-14T17:38:25.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151480

FDA has approved a higher 2 mg dose of Novo Nordisk’s Ozempic (semaglutide) injection, a once-weekly glucagon-like peptide-1 analog indicated along with diet and exercise to improve blood sugar in adults with Type 2 diabetes and to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with Type 2 diabetes and known heart disease. With this approval, the company [says](https://www.prnewswire.com/news-releases/novo-nordisk-receives-fda-approval-of-higher-dose-ozempic-2-mg-providing-increased-glycemic-control-for-adults-with-type-2-diabetes-301512209.html?tc=eml%5Fcleartime&ref=fdaweb.com), Ozempic will be available in three dosage levels.